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1. Introduction 
A P-interferon-resistant subline of mouse leukemia 
L-l 210 cells (L-l 210R) has been isolated and cloned 
after prolonged culture of L-1210 cells in the pres- 
ence of this interferon [I]. Its resistance to antiviral 
and antigrowth effects of mouse P-interferon is caused 
by the absence of functional receptors [2,3]. The ini- 
tial step in P-interferon action may involve binding to 
cell membrane gangliosides of target cells, since this 
interferon interacts with the carbohydrate portion of 
these glycolipids [4-61. To investigate whether the 
absence of functional receptors on L1210R cells cor- 
relates with a lack of specific gangliosides, we have 
compared the ganglioside pattern of parent L-1210 
cells with that of its receptor-negative mutant, 
L-1210R. Our data show identical gangliosides in 
both types of cells and reveal the same proportions of 
NWacetylneuraminyl- a&N-glycolylneuraminyl-GM3 
in their cell extracts. Thus interferon resistance and 
lack of high affinity binding in L-1210R cells cannot 
be attributed to an altered ganglioside pattern in this 
subline. 
2. Materials and methods 
2.1. Cells 
Abbreviations: N-acetyhreuraminylGM3,3-0-olfl-acetyl- 
neuraminyl-4-O~galactosyl-Oglucosyl-ceramide;Nglycolyl- 
neuraminylGM3,3-O-cu-Nglycolylneuraminyl-4-O-p-galacto- 
syl-Oglucosyl-ceramide; GM2,4-O$-N-acetylgalactosaminyl 
(3-O-cY-N-acetylneuraminyl)4-OQ-galactosyl-Oglucosyl- 
ceramide; GD~, 8-0-o-N-acetylneuraminyl-3-O-a-N-acetyl- 
neuraminyWO$galactosyl-Oglucosyl-ceramide; GML, 
3-OpgalactosyWO$-N-acetylgalactosaminyl (3-O-o-N- 
acetyhteuraminyl4-0~galactosyl-Oglucosyl-ceramide; 
GDla, 3-0-a-N-acetylneuraminyl-3-Op-galactosykl-0$-N- 
acetylgalactosaminyl (3-0-or-N-acetylneuraminyl)-4-OQ- 
galactosyl-Oglucosyl-ceramide; G*Lb, 3-O$galactosyWO- 
p-N-acetylgalactosaminyl (8-0-or-Nacetylneuramide-3-O-o-N- 
acetyIneuraminyl)4-OQgalactosyl-Oglucosyl-ceramide; 
GTlb, 3-0-o-Nacetylneuraminyl-3-OpgalactosyWOQ-N- 
acetylgalactosaminyl(8-O-or-N-acetyhreuraminyl-3-O-cu-N- 
acetylneuraminyl)-4-OQgalactosyl-Oglucosyl-ceramide; 
Mu-IFNQ, murine p-interferon; TLC, thin-layer chromatog- 
raphy 
L-1210 parent cells (L-1210s) and the Mu-IFN-/I- 
resistant subline (L-1210R) were kindly provided by 
Ion Gresser. They were grown in RPM1 1640 medium 
(GIBCO) supplemented with 10% fetal bovine serum 
under static conditions at 37’C to a final density of 
2-3 X 1 O6 cells/ml. Just prior to harvesting large 
batches of cells, aliquots were removed and suspended 
to 10’ cells/ml in RPM1 1640 medium plus 5% fetal 
bovine serum with or without 1000 NIH reference 
units/ml of Mu-IFN-/3 to assure unchanged sensitivity 
of L-1210s and resistance of L-1210R cells to its 
growth-inhibitory effect at the time of harvest. Cell 
counts after further 3 days of growth revealed 50% 
less L-l 21 OS cells in the interferon-treated samples 
as compared to control counts, and no difference 
between interferon-treatedand control G1210R cells. 
2.2. Reagents 
* To whom correspondence should be addressed 
Mouse fibroblast interferon was supplied by Kurt 
Pauker (2 X 1 O7 NIH reference units/mg). Individual 
gangliosides were from Seromed (Munich). N-Glycolyl- 
neuraminyl-lactosyl-ceramide was kindly provided by 
Subhash Basu, (N-acetyl-neuraminyl)Tlactosyl-cera- 
mide (GD3) was isolated from bovine brain [ 71. 
N-Acetylneuraminic acid, N-glycolylneuraminic acid, 
lactosyl-ceramide and Clostridium perfringens new- 
aminidase were from Sigma. 
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2.3. Extraction of cells 
Cells (-log/batch) were isolated by centrifugation 
and washed repeatedly with cold PBS. The packed 
cells were then extracted with chloroform--methanol 
(2: I,40 rn; solvent/3 ml cell pellet) using a Brinkman 
Polytron for 10 min to homogenize the cells in the 
solvent. After centrifugation the same process was 
repeated twice followed by 3 more identical extrac- 
tions using chloroform-methanol (1:2). Supernatants 
of all extractions were combined and concentrated on 
a rotary evaporator to a small volume, then taken to 
dryness in small conical tubes by a stream of nitrogen. 
Samples were stored at 0°C until further analysed. 
2.4. Neuraminidase treatment 
Commercial Clostridium perfringens neuraminid- 
ase was desalted on a small column of Sephadex G-SO. 
Individual ganglioside samples (1 O-50 nmol) were 
digested with 1.3 units of neuraminidase in 0.1 ml 
water for 1 h at 37°C and lyophilized prior to thin- 
layer chromatography. Under the conditions used 
C. perfringens neuraminidase quantitatively removes 
sialic acid from authentic N-acetylneuraminyl-GM3, 
N-glycolylneuraminyl-GM3 and GD3, but does not 
hydrolyse GM2- or GM,-bound sialic acid. 
2 5. Other analytical procedures 
Thin-layer chromatography was done with poly- 
(ethylene terephthalate)backed silica gel sheets 
(Eastman Kodak Co.). The solvents used were chloro- 
form-methanol-2.5 N NHqOH (60:40:9, by vol., 
solvent 1) and chloroform-methanol-0.25% KC1 
(60:40:8, by vol., solvent 2). Sialic acid-positive spots 
were identified by resorcinol spray [8]. Ratios of 
individual gangliosides were determined after scraping 
corresponding resorcinol-positive areas, extracting 
with 0.5 ml butanol-butyl acetate (85: 15, v/v) and 
determining the absorbance of the cleared extracts at 
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Fig.1. Separation of gangliosides from L-1210s (S) and L-1210R (R) cells by TLC in solvents 1 (left) and 2 (right). The standards 
are: (A) GTlb; (B) GDlb; (C) GDla; (D) GML; (E) GM2; (F)N-acetylneuraminy1-G MS; (M) mixture of (A-F). Di-sialoganglioside 
CD3 migrates slightly ahead of GM1 and slower than GM~ in solvent 2 (not shown). The only two blue-staining spots characteristic 
for sialic acid-containing glycolipids in R and S where those migrating like authentic N-acetyLneuraminy%MS and slightly ahead 
of GM2. Faster-moving spots stained brownish-yellow and represent non-ganglioside lipid contaminants. Spots slower than GDLb 
in solvent 1 represent traces of free sialic acids that arose during storage of the glycolipid extracts due to some degradation of the 
gangliosides and were absent on chromatograms of freshly prepared extracts (see solvent 2, right). 
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580 nm. Lactosyl-ceramide was localized by the 
cw-naphthol spray [ 81. Sialic acid was determined with 
resorcinol [9]. The same molar amounts of N-acetyl- 
and N-glycolyl-derivatives yield identical A-values at 
580 nm [lo]. Cell counts were done using a hemo- 
cytometer. 
3. Results 
Determination of total sialic acid in chloroform- 
methanol extracts yielded 0.6 g/lo6 L-1210s cells 
and 0.8 pg/106 L-1210R cells. This difference, most 
likely due to the error involved in individual cell 
counts, does not reveal a deficiency of lipid-bound 
sialic acid in L-l 210R cells as compared to L-l 210s 
cells. 
There were only 2 detectable sialic acid-contain- 
ing glycolipids in the extracts of either L-1210s or 
L-1210R cells (fig.1). The faster moving components 
from each cell type had identical mobilities in the 
neutral and the alkaline solvents used. The same was 
found for the slower moving components. The faster 
moving spots migrated identically to N-acetylneur- 
aminyl-GMg, and the slower moving spots slightly 
ahead of GM2 and identically to N-glycolylneuraminyl- 
GM3, as shown below. 
Extraction of individual resorcinol-stained spots 
with butanol-butyl acetate followed by spectro- 
photometric determination revealed 20 f 3% of total 
resorcinol colour in the upper spots and 80 + 3% in 
the lower spots for both L-1210s and L-1210R cell 
extracts. 
The resorcinol-positive components of L-1210s 
and L121 OR cell extracts were separately isolated 
using preparative TLC. Extracts from 5 X lOa cells 
were applied in narrow lines on the TLC sheets and 
separated in solvent 2. Guide strips were cut off on 
each side of the sheets and developed with resorcinol 
spray. Zones on the non-developed sheets correspond- 
ing to resorcinol-positive areas were scraped and 
extracted with 1 ml chloroform-methanol (2: 1) 
3 times. Combined supernatants were brought to dry- 
ness and aliquots subjected to TLC. Complete separa- 
tion of the glycolipids was achieved for solvent 1 
(fig.2): the faster spots migrated like N-acetylneur- 
aminyl-GM,, and the slower spots identically to 
N-glycolylneuraminyl-GM3. The same was observed 
in solvent 2 (not shown). Treatment with neuramin- 
idase released N-acetylneuraminic acid from the faster 
Fig.2. TLC of individually separated gangliosides from L-1210s 
and L-l 210R cells in solvent 1. R, and S, are upper spots, 
and R, alid S, ldwer spots from the respective cell extracts 
that were isolated after preparative TLC of each extract. The 
standards are: (D) GM1 ; (E) GM2; (F) N-acetylneuraminyl- 
GM~; (G)f@ycolylneuraminyl~M3; (M) mixture of (D-G). 
Faint spots in R, and S, ahead of N-acetylneuraminyl-G~3 
are brownish yellow-staining non-ganglioside contaminants. 
moving glycolipids, and N-glycolylneuraminic acid 
from the slower-moving glycolipids, as indicated after 
TLC in solvents 1 (fig.3) and 2 (not shown). The 
a-naphthol spray revealed spots corresponding in 
mobility to authentic lactosyl-ceramide in all 4 neur- 
aminidase-treated samples (solvents 1 and 2), which 
were absent in non-treated controls. Thus all 4 gan- 
gliosides have sialic acids as non-reducing terminals, 
the faster-moving ones contain N-acetylneuraminic 
acid, and the slower-moving spotsN-glycolylneuraminic 
acid. Since neuraminidase treatment released lactosyl- 
ceramide from all 4 gangliosides, and since all 4 were 
chromatographically distinguishable from G,,, it fol- 
lows that the faster-moving spots are N-acetylneuram- 
inyl-lactosyl-ceramide, and the slower-moving spots 
N-glycolylneuraminyl-lactosyl-ceramide. 
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Fig.3. Separation of sialic acids released from individual gan- 
gliosides after treatment with neuraminidase: Ru and S,, 
from the respective upper spots, and R, and S, from the 
respective lower spots of L-1210R (R) and L-1210s (S) cell 
extracts. The standards are: (H) N-acetylneuraminic acid; 
(I) N-glycolylneuraminic acid. Spots migrating ahead of 
IV-acetylneuraminic acid in R, and S, are brownish yellow- 
staining contaminants. 
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4. Discussion References 
The ganglioside patterns of L121OS cells and of 
the /3-interferon-resistant subllne L1210R are very 
similar, qualitatively as well as quantitatively. The 
absence of higher gangliosides is comparable to other 
B-lymphocytic mouse tumor lines, which likewise 
lack significant amounts of gangliosides more complex 
than GM3 [ 111. When exogenously added to target 
cells together with interferon, N-acetylneuraminyl- 
GM~ [6] andN-glycolylneuraminyl-~3 (unpublished) 
are inhibitory to the antiviral action of Mu-IFN-/I and 
thus can bind to it. Since carbohydrate residues of 
cell membrane gangliosides are exposed on the outside 
of the cell, binding of pinterferon to these carbo- 
hydrate residues could conceivably be the initial event 
that preceeds its biological action. However, if inter- 
action of fl-interferon with either or both of the 
gangliosides present in L121OS cells was responsible 
for binding to its receptor, the same high affinity 
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binding should also occur with L1210R cells, as both 
cells show very similar ganglioside patterns. 
The affinity of binterferon for cell membrane 
gangliosides may not be sufficient to allow for high 
affinity binding to target cells and their carbohydrate 
chains may not participate in productive interac- 
tion with the interferon molecule. The dissociation 
constant for the receptor Mu-IFN-/3 complex on 
L-1210s cells is in the picomolar range (10-l’ M in 
[2]). However, lo-100 PM ganglioside have to be 
employed to inhibit antiviral and antigrowth effects 
[6]. The fact that binding of pinterferon to L1210S 
cells is trypsin-sensitive suggests that an important 
part of the receptor is protein or glycoprotein in 
nature [3]. Thus, the observed binding of Pinter- 
feron to isolated gangliosides might be the result of 
its affinity for carbohydrate side chains on sialic acid- 
containing glycoprotein receptors which are structur- 
ally similar to those found on gangliosides. 
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